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Environmental health research can present
challenges to institutional review boards
(IRBs) and others charged with protecting
the rights and welfare of research partici-
pants (1). Existing regulatory guidelines on
research involving human subjects were
developed primarily for clinical investiga-
tions, making their application to epidemio-
logic and community-based research
problematic (2). Where epidemiologic stud-
ies present limited risks to participants, for
example, clinical standards for informed
consent may be inappropriate (3).
Conversely, in community-based studies
that present risks to all community mem-
bers, existing regulatory standards focused
on the protection of individual research sub-
jects may be insufﬁcient (4).
Concerns of this second sort—that is,
concerns about research-related harm to
identifiable communities—have been
spurred on by advances in genetic technolo-
gies (5). Studies of human genetic variation
can present risks to all members of a social
group, not just those individuals who choose
to participate in research (6). Findings that
associate an ethnic group with a genetic pre-
disposition to disease, for example, could
lead to group discrimination or stigmatiza-
tion (7). Such risks have been the subject of
much discussion surrounding studies of the
so-called breast cancer genes BRCA1 and
BRCA2, as some polymorphisms in these
genes appear to be more common among
persons of Jewish ancestry, specifically
Ashkenazi Jews (8). This ﬁnding creates the
possibility that all Ashkenazi Jews may be
asked to pay higher insurance premiums or
face other more subtle forms of discrimina-
tion on the basis of the apparent association
between these genetic variants and increased
risk of developing breast cancer (9). These
collective risks are not unique to genetic
research, however (10). Studies of population-
speciﬁc characteristics, research on stigmatiz-
ing behaviors in a particular community, or
the identiﬁcation of local environmental cont-
aminants can present risks to all members of a
study population. Nonetheless, current fed-
eral regulations governing research with
human subjects do not require researchers or
ethics review boards to consider potential
harm to nonparticipants (11).
In response to this apparent regulatory
gap, the National Bioethics Advisory
Commission (NBAC), a presidential com-
mission on the protection of human subjects
in research, has proposed that regulatory
oversight be extended to include the protec-
tion of social groups (12). The NBAC rec-
ommendations, presented in the report,
“Research Involving Human Biological
Materials: Ethical Issues and Policy
Guidance,” maintain that in addition to
considering potential risks to individual
research volunteers, investigators and review
boards should consider how to minimize
group harms (Recommendation [Rec.] 17).
When signiﬁcant risk to an identiﬁable com-
munity can be identiﬁed before a study has
begun, the commission suggests that
researchers work directly with community
representatives to develop study methods
that minimize the potential for harm (Rec.
17) and discuss collective risks as part of the
informed consent process (Rec. 18). The
commission also recommends that in report-
ing research results, investigators and journal
editors consider potential implications for
social groups (Rec. 19).
The NBAC recommendations, if adopted
by investigators and ethics review committees,
would signiﬁcantly extend regulatory perspec-
tives beyond their present focus on risks to
individual participants. Like other commenta-
tors on the protection of human subjects in
research (13–15), we support this regulatory
expansion. Developing additional oversight
policies designed to protect identifiable
groups is an important part of acknowledging
the broader social implications of contempo-
rary biomedical research and the need to
think more expansively about the conse-
quences of research practices. Nonetheless, we
also recognize that soliciting community
views regarding ethical conduct and responsi-
ble research practices can be difﬁcult (16,17).
In this article we describe some of the
beneﬁts and challenges of directly involving
communities in the ethical review of
research. The analysis we propose focuses on
genetic research with American Indian and
Alaska Native communities, as several partic-
ipatory models have been tried in these con-
texts (18). We believe these experiences with
indigenous communities can illuminate
broader ethical issues and practical chal-
lenges present in research studies involving
other historically disadvantaged communi-
ties. Because there have been few successful
examples of direct consultation with com-
munities in the design of appropriate ethical
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agenda to develop best practices for consult-
ing local communities regarding the ethical
conduct of epidemiologic and environmen-
tal health research.
Protecting Communities from
Research-Related Harm
As noted above, existing regulatory policies
and ethical guidelines concentrate on imme-
diate risks to individual study participants and
do not require researchers or ethics review
boards to consider potential harms to nonpar-
ticipants (11,19). Thus, the recommendations
proposed by the presidential commission rep-
resent a significant departure from current
regulatory perspectives. Nonetheless, a com-
pelling case can be made in support of the
idea that when research studies place nonpar-
ticipating members of social groups at risk,
these potential harms should be considered by
persons conducting, reviewing, and partici-
pating in research (4). The potential beneﬁts
of addressing collective research-related
harms include a more complete appreciation
of the risks and beneﬁts of research, increased
public conﬁdence in the research enterprise,
and the promotion of increased diversity
among research participants. Considering
potential group harms also demonstrates
respect for the diverse social and cultural tra-
ditions of many communities and acknowl-
edges that research ﬁndings can disrupt social
relationships within and between communi-
ties. These considerations suggest that pro-
tecting identifiable communities from
research-related harm is a moral imperative
in conducting and reviewing research (20).
Under current federal regulations, ethics
review boards are required to include at least
one community representative. There are
times, however, when this is inadequate and
the involvement of community representa-
tives requires more elaborate consultation
with members of the communities placed at
risk, as often is the case in research with
American Indian and Alaska Native commu-
nities and studies conducted outside the
United States (21,22). In many cases,
directly involving members of identifiable
social groups, particularly members of his-
torically underserved communities (e.g.,
communities of color, patient communities,
or occupational communities), in the ethical
review of research can help identify local
risks that otherwise might go unnoticed.
A recent study of the effects of polychlo-
rinated biphenyls on the health of American
Indians living along the St. Lawrence River
illustrates some of the potential beneﬁts (and
drawbacks) of soliciting community perspec-
tives on the ethical conduct of environmental
health research (23). The cooperative rela-
tionship between the Akwesasne people and
scientists at State University of New York
(SUNY; Albany, NY) was based on three
principles: mutual respect, mutual equity,
and mutual empowerment (24). These guid-
ing principles were jointly agreed upon by
community representatives and members of
the research team from SUNY. Approval of
the research was obtained from both the
Akwesasne community and individual
research participants. Project goals were
determined jointly and designed to maximize
data quality while simultaneously minimizing
the disruption of community activities.
Community members were involved in the
project as research assistants, and after receiv-
ing proper training, these research assistants
collected tissue samples and conducted inter-
views. The SUNY researchers believed the
success of their research project was based
largely upon the early stage at which the
cooperative relationship with the Akwesasne
developed, the formal approval of the study
given by the Akwesasne, the participation of
community members as field staff, the
involvement of community partners in com-
municating research results, and shared
authorship on the publication of research
papers and reports (25).
The success of projects like this illus-
trates how the commission’s proposals might
be implemented and what beneﬁts might be
expected (26). Nonetheless, we should
acknowledge the limitations of this
approach. In the following sections we high-
light two difficulties facing proposals to
expand the scope of regulatory oversight to
include the protection of social groups: how
best to anticipate potential research-related
harms to identiﬁable communities, and how
best to manage the many practical challenges
of expanding an already overburdened regu-
latory system. We again examine these two
challenges in the context of research with
American Indian and Alaska Native commu-
nities, as research with indigenous commu-
nities, particularly genetic research, has
received considerable attention from com-
mentators on ethical issues in research.
Although it would be a mistake to naïvely
generalize from these research settings to
studies involving other identiﬁable commu-
nities where very different social relation-
ships may characterize collective interests
and concerns about biomedical and genetic
research, we believe it behooves us to con-
sider the lessons to be learned from past
experience with American Indian and Alaska
Native communities.
Anticipating and Assessing
the Signiﬁcance of Group
Harms
No protectionist policies or regulatory struc-
tures can fully embody their guiding moral
principles or anticipate all ethical issues that
might emerge over the course of a research
study (27). Nevertheless, the protection of
nonparticipants and socially identiﬁable com-
munities is particularly difﬁcult to capture in
regulatory language because of problems sur-
rounding the deﬁnition of an affected com-
munity (28–31). Often, at the beginning of a
study it is not clear which particular social
groups will be affected by the research—
much less how they might be affected.
Similarly, there are numerous challenges sur-
rounding how best to capture abstract
notions such as “respect for communities” in
formal research guidelines. As a result, inves-
tigators sincerely committed to conducting
research in an ethical and respectful manner
(and who are familiar with guidelines for eth-
ical conduct in research) can nonetheless
struggle with how to apply these guidelines
and principles in the context of their studies.
These and related problems are evident when
one considers the commission’s recommen-
dations more carefully.
The commission’s recommendations
hinge on the ability of researchers or IRB
members to anticipate collective research-
related harms prospectively. Consider Rec.
17, the most detailed of the commission’s
proposals pertaining to group risks (12):
Research using stored human biological materi-
als, even when not potentially harmful to indi-
viduals from whom the samples are taken, may
be potentially harmful to groups associated with
the individual. To the extent such potential harms
can be anticipated [emphasis added], investigators
should to the extent possible plan their research
so as to minimize such harm and should consult,
when appropriate, representatives of the relevant
groups regarding study design. In addition, when
research on unlinked samples that poses a signiﬁ-
cant risk of group harm is otherwise eligible for
exemption from IRB review, the exemption
should not be granted if IRB review might help
the investigator to design the study in such a way
as to avoid those harms.
Although the type of community consul-
tation proposed by the commission is useful
in addressing collective risks that have been
identified prior to the start of a study, this
approach is limited by the fact that even
experienced researchers and IRB members
can fail to anticipate significant research-
related risks before a study begins (4). For
example, researchers and reviewers can ﬁnd
it especially difﬁcult to identify risks involv-
ing the disruption of social relationships
within communities of which they have little
knowledge or familiarity. Similarly, risks that
researchers or review boards view as minor
may be viewed by study participants (or
other members of the group placed at risk)
as substantial.
These difficulties can be seen in two
examples from research with American
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Studies of population histories and patterns
of population migration can affect the legal
standing of claims made by sovereign Native
American tribes for the repatriation of
human remains or the return of tribal arti-
facts held in federal museums (33).
Researchers unfamiliar with these repatria-
tion efforts are unlikely to anticipate such
potential risks, although they may be quite
salient to members of those communities.
Similarly, studies involving genetic markers
found more commonly in American Indian
and Alaska Native populations can disrupt
the social equilibrium that exists within a
community by revealing that participants
and their families are more “European” in
ancestry than they themselves believe. Such
findings have social consequences in many
indigenous communities, as the ability to
occupy a political ofﬁce often is contingent
upon establishing one’s ancestry as suffi-
ciently “Native” (34). Here too, it is unlikely
that researchers who are not themselves
members of these communities could antici-
pate such research-related risks or fully
appreciate their signiﬁcance for the commu-
nity and its members.
The challenge of identifying potential
group harms is especially difficult when
researchers never have direct contact with
members of the study population (35,36).
Because many types of environmental
health research can be done using informa-
tion or biological samples that were col-
lected for unrelated purposes (e.g.,
epidemiologic studies based on previous
exposure assessments), researchers and the
individuals from whom information or
samples have been collected may never
interact with each other. Additionally, as
new risks may present themselves as the
research progresses, it is important that
consultation with members of study popu-
lations continue throughout the process of
data collection, analysis, and reporting.
These difficulties highlight the impor-
tance of early and ongoing involvement of
community representatives in the review of
research proposals. To the extent that the
commission’s proposal depends upon the
ability to anticipate group harms at the
beginning of a research study, and many
local or population-specific risks may still
go unnoticed if there is signiﬁcant sociocul-
tural distance between members of the
research team and study participants, the
commission’s recommendations are prob-
lematic. This is unfortunate, as it is pre-
cisely in those circumstances where
collective risks are difficult to identify
prospectively that the involvement of local
study populations is most critical for mini-
mizing potential harm.
Expanding the Scope of
Regulatory Oversight: Future
Research Needs
The expansion of regulatory oversight to
include the protection of social groups would
have signiﬁcant consequences for a regulatory
system that many believe is overburdened and
undersupported (17,37). Thus, it is under-
standable why the commission attempted to
limit community involvement in the ethical
review of research to those studies in which
signiﬁcant group harms could be anticipated.
Interestingly, applying this anticipatory prin-
ciple would not only preclude the involve-
ment of community representatives from
some studies in which community consulta-
tion is critical for the identiﬁcation of collec-
tive risks (as noted above) but would expand
the scope of regulatory oversight to include
many types of research currently viewed as
exempt (e.g., research using anonymous sam-
ples from identifiable populations). This
highlights a second challenge facing proposals
to involve community members in the ethical
review of research, namely, how to deﬁne the
range of research studies where community
consultation is needed.
One way to address this practical chal-
lenge is to concentrate on involving commu-
nity representatives at the earliest possible
stage in the research process. If this approach
is used, attention should be given to the dif-
ferent methods through which community
views might be solicited. Because presum-
ably some studies require more involved
community participation than others
(because of the level of collective risk pre-
sented), the question becomes which features
of the community and/or study can be used
to determine the nature and extent of this
involvement. For example, researchers might
solicit input from participating communities
through relatively informal mechanisms,
through the identification of a subset of
community members that are broadly repre-
sentative of community interests, or by
actively involving communities as research
partners (4). In addition, as the balance of
research benefit and harm can change over
the course of an investigation, it is important
to assess the effectiveness of various oversight
mechanisms in protecting group interests
throughout the entire duration of a research
study. Examining the respective merits and
problems with various approaches to com-
munity consultation and partnership and
describing best practices with regard to each
are essential to the continued development
of policy in this area.
Of particular importance are empirical
studies assessing how various social, reli-
gious, economic, cultural, and political com-
munities view risks associated with research.
Presently, little is known about how mem-
bers of various underserved or marginalized
communities weigh individual research risks
against group risks, how salient collective
risks are in relation to other risks encoun-
tered in daily life, or how individuals
attempt to reconcile potential conﬂicts that
may exist between personal interests in
research participation and collective opposi-
tion to proposed research. Because not all
collective harms carry the same weight—that
is, some group harms are more significant
than others—it is important to assess how
members of historically underserved com-
munities evaluate collective research-related
harms. Moreover, without such information
it will be difﬁcult, if not impossible, to tailor
oversight processes to speciﬁc communities.
There also is need for additional ethical
and philosophical analysis of the goals of
involving community representatives in the
review of research. Whereas members of the
presidential commission appear to view com-
munity involvement as a supplemental
method of identifying risks, others have
described the involvement of community
representatives as something akin to seeking
individual informed consent (38).
Proponents of this second perspective main-
tain that there are reasons for involving com-
munity representatives in the review of
research that are distinct from efforts to pro-
tect such groups. For example, seeking com-
munity advice can show respect for different
cultural perspectives on how to balance indi-
vidual and group interests in research.
Further conceptual analysis is necessary to
determine whether these are distinct value
commitments and how the various goals of
community consultation are served to greater
or lesser degrees by different approaches to
working with community representatives.
Another key area in which additional con-
ceptual analysis is much needed concerns the
notion of collective harm. Like individual
harms, research-related harms to communities
can be of two sorts—tangible and dignitary.
Tangible collective harms include discrimina-
tion or stigmatization of community mem-
bers, loss of social opportunities, and so forth.
Dignitary harms to communities, by contrast,
involve violations of collective rights or disre-
spectful treatment of the affected community.
For example, using stored biological materials
in a manner that the community would ﬁnd
morally objectionable can constitute a digni-
tary harm not only to the individuals who
contributed those materials but to the com-
munity as a whole. How to assess the ethical
salience of dignitary harms to communities
and how to determine which of these harms
are significant and which are not remains
largely unexplored in the philosophical litera-
ture on community consultation in research.
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important to acknowledge in a very clear
and candid way that expanding the scope of
federal oversight to include the protection of
identiﬁable communities will require a sub-
stantial investment of resources. Indeed, it
may be the case that the additional costs
(and practical difficulties) of developing
these protections will result in fewer research
studies being conducted, raising difficult
issues regarding the proper balance between
protectionist concerns and concerns for the
advancement of knowledge. Although con-
siderations of cost and practicability are
inevitable features of biomedical research, we
hope that these concerns are not allowed to
trump discussions surrounding the develop-
ment of new regulatory policies. Additional
empirical data and conceptual analyses will
be critical to resolving these questions about
when some type of community consultation
is needed and how it can be best carried out
in the context of speciﬁc communities.
Conclusion
We have identiﬁed several challenges facing
the expansion of regulatory oversight to
include the protection of identifiable com-
munities. Sociocultural distance between
researchers and members of study popula-
tions can make it difficult to identify and
fully appreciate the signiﬁcance of collective
research-related risks. This makes regulatory
proposals based on the anticipation of collec-
tive risks problematic. Implementing new
oversight requirements also would place sig-
nificant strain on an already overburdened
regulatory system. Thus, how to accomplish
this regulatory expansion is complicated by
the need to develop clear principles for
determining when additional oversight
mechanisms should apply.
These difﬁculties suggest that protecting
social groups from research-related harm is
far more nuanced than the analysis suggested
by the commission. Nevertheless, the com-
mission should be commended for its
efforts. Their recommendations are the ﬁrst
substantive attempt by a national advisory
group to advance regulatory protections
beyond their current focus on individual
risks and beneﬁts. In proposing this regula-
tory expansion, the commission has raised a
number of profound questions about how to
balance individual and collective interests in
research, as well as questions about what the
goals of research guidelines should be with
regard to meeting the needs of historically
underserved communities. Thus, perhaps
the most significant contribution of the
NBAC report will be its promotion of con-
tinuing dialogue on the identification of
risks to social groups, irrespective of whether
investigators or regulatory agencies choose to
adopt the commission’s recommendations.
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